You can choose from the following courses:
This course equips HCM students with theoretical perspectives and practical knowledge on strategy and strategic financial management in healthcare organizations. Students will develop an understanding of how strategic decisions translate into financial consequences, how financial information supports strategic decision-making, and how healthcare organizations justify and monitor their financial performance. Rather than training financial specialists, the course prepares future healthcare managers to engage confidently and meaningfully with accountants, controllers, and other financial professionals, enabling them to critically evaluate the financial dimensions of strategic choices and participate effectively in strategic decision-making.
Employees are of crucial importance for the delivery of health care and the performance of health care organisations. Therefore, the management of health care organisations involves managing people. This course aims to provide insights in the behaviour of individuals who are embedded in professional groups, teams, hierarchical structure within an organisation, and organisational context.
Read more in the course catalogue
Quality and safety are very much on the agenda of health care governance throughout the world. In this course we engage students to actively explore theoretical backgrounds to, as well as the major themes of, quality and safety governance. In general, the course takes the position that quality and safety in health care are emergent properties that need continuous work. Consequences of specific interventions to improve quality and safety are often unpredictable, hence we take the position that a straightforward ‘how to’ improve quality and safety is, at best, not very productive. Instead, we emphasize in this course the need for both ‘top-down’ and ‘bottom-up’ approaches to quality and safety, and place particular stress on theories of the 'middle' - the level where the work of management and leadership usually resides. The course explores six challenges that come from this 'mangle of the middle'. These challenges are said to face each quality and safety improvement effort, and can be structural, political, cultural, technological, emotional and educational.
Read more in the course catalogue
You can choose from the following courses:
The course Pharmaceutical Pricing and Market Access (PPMA) aims to provide students with a detailed understanding of this complex and changing market. We will follow each step of the life cycle of a drug, from phase II clinical trials up to post-launch, integrating both market access theory and examples from the real world. We will discuss the importance of optimizing product launches, real world post marketing studies and innovative pricing agreements. Students will gain insight into how the latest changes in regulations, guidelines and stakeholders in the major EU, US and BRIC countries impact the success of brands, as well as the interactions between all the actors on the markets. They will learn to understand how differences between healthcare systems impact optimizing market access for pharmaceutical products.
Read more in the course catalogue
How can we find out why countries that are similar in many ways sometimes have very different healthcare policies? Or, the other way around, why countries that at first sight appear to be very different, turn out to have rather similar policies? The aim of this course is to provide you with theoretical perspectives and methodological tools to answer the question of how to perform a comparative health policy analysis to explain cross-country differences and similarities.
Read more in the course catalogue
This course is about the interaction between public health, economics, and public health policy. Good health policies are impossible to formulate without an understanding of the relation between public health policies, individual behaviour and population health. In this course students will be taught how to apply statistical methods and economic theory to questions such as: “What are the determinants of population health?” “How should we measure and summarize population health?”, “Which policies are effective in improving population health?” and “How should policymakers address future challenges in public health?”.
Cost-effectiveness studies aim to evaluate the value of innovative health technologies in relation to current standards of care by comparing both their costs and health outcomes. These studies are typically supported by cost-effectiveness models, such as decision trees, partition survival models and Markov models. The foundational principles of cost-effectiveness modelling were introduced in previous courses. In this advanced course, we will explore topics including advanced model structures, survival analysis, model validation, sourcing cost and utility inputs, and incorporating sensitivity analysis into your model. This course is essential for all students who are planning to develop a cost-effectiveness model as part of their thesis work.
Disease burdens across low- and middle-income countries (LMICs) are changing and up to a billion people have no, or limited access to necessary health care. The ageing population globally and the increased prevalence of non-communicable diseases are placing a heavy burden on health care systems, especially across LMICs. Health care financing tends to be constrained, especially with high income countries significantly reducing external aid. Through a range of health care system reforms, LMICs strive for domestically-led progress on the path towards “Universal Health Coverage”: good quality health care for all without causing financial hardship.
Read more in the course catalogue
In this multidisciplinary course, students are introduced to (i) determinants of market structure, prices, quality, provider networks and competition in health insurance and provider markets as well as (ii) the basic principles of competition law. Unique attributes in health care not only affect the functioning of market-based health care systems, but also complicate competition enforcement. Therefore, competition (or: antitrust) enforcement in the health care sector is also extensively discussed.
Read more in the course catalogue
This course equips you with tools of economic analysis that you can use to explain the distribution of health and healthcare, to evaluate spending on healthcare in aggregate and across treatments, and to evaluate health policies. It covers the main models used in economics to analyze determinants of health and health behaviour. It gives an understanding of concepts that you will apply in modules such as Health Technology Assessment, Public Health Economics and Global Health Economics, and it will help you understand how the material covered in these modules fits within the field of health economics.
Read more in the course catalogue